AIM
Alerce Investment Management Portfolio holdings
AUM
$56.8M
This Quarter Return
-16.2%
1 Year Return
+31.17%
3 Year Return
+25.12%
5 Year Return
–
10 Year Return
–
AUM
$184M
AUM Growth
+$184M
(-18%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
7
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
American Well
AMWL
$111M
| $79.3M | 43.02% |
6,300,773
| – | – |
|
2
Annexon
ANNX
$226M
| $44M | 23.89% |
1,954,978
| – | – |
|
|
RNTX
3
Rein Therapeutics, Inc. Common Stock
RNTX
$32M
| $20.8M | 11.27% |
16,609,449
| – | – |
|
4
Akebia Therapeutics
AKBA
$833M
| $17.6M | 9.57% |
4,652,561
| – | – |
|
|
WHWK
5
Whitehawk Therapeutics, Inc. Common Stock
WHWK
$84.8M
| $9.5M | 5.16% |
5,621,835
| – | – |
|
6
Assembly Biosciences
ASMB
$190M
| $8.64M | 4.69% |
2,227,500
| – | – |
|
|
GBT
7
DELISTED
Global Blood Therapeutics, Inc.
GBT
| $4.42M | 2.4% |
126,270
| – | – |
|